Literature DB >> 24724576

Effect of voriconazole and ultraviolet-A combination therapy compared to voriconazole single treatment on Fusarium solani fungal keratitis.

Kyoung Sub Choi1, Sang Chul Yoon, Tyler Hyung Taek Rim, Soo Jung Han, Eun-Do Kim, Kyoung Yul Seo.   

Abstract

PURPOSE: To demonstrate that ultraviolet-A (UV-A) and voriconazole combination therapy is more effective than voriconazole single treatment for fungal keratitis.
METHODS: The in vitro UV-A (375 nm) fungicidal effect was evaluated on Fusarium solani solutions. Each fungal solution was irradiated with different UV-A irradiation doses. Also, a fungal solution containing voriconazole was also irradiated with UV-A. The in vivo therapeutic effect of UV-A and voriconazole treatment was studied in a rabbit keratitis model. Fungi were injected intrastromally into the cornea of 16 rabbits. Each treatment was initiated 3 days after fungal injection and continued up to 8 days for the following groups: Group 1, control; Group 2, treated with UV-A once a day; Group 3, treated with voriconazole 3 times a day; Group 4, treated with voriconazole 3 times a day and UV-A once a day. On the last day, the sclera-cornea buttons were extracted and microbiological and histological evaluations were performed.
RESULTS: The colony-forming units (CFUs) of fungal solutions in culture significantly decreased with UV-A irradiation. The CFUs of fungal solutions containing voriconazole also decreased with UV-A irradiation. In vivo, clinical scores of Group 3 (P=0.03) and Group 4 (P=0.02) 5 days after treatment were significantly lower compared to that of Group 1. The clinical score of Group 4 (P=0.03) 5 days after treatment was significantly lower compared to that of Group 3. The histopathological scores 5 days after treatment were significantly lower in Group 4 compared to those of Group 1 (P<0.01) and Group 3 (P=0.02). Based on our CFU analysis, only Group 4 showed significantly lower CFUs compared to Group 1 (P=0.04).
CONCLUSIONS: UV-A and voriconazole combination treatment could be a safe and effective alternative to voriconazole single treatment for fungal keratitis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24724576      PMCID: PMC4043359          DOI: 10.1089/jop.2013.0167

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  20 in total

1.  Effectiveness of germicidal UV radiation for reducing fungal contamination within air-handling units.

Authors:  E Levetin; R Shaughnessy; C A Rogers; R Scheir
Journal:  Appl Environ Microbiol       Date:  2001-08       Impact factor: 4.792

2.  CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype.

Authors:  Kazuya Kitamura; Joshua M Farber; Brian L Kelsall
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

Review 3.  Safety of UVA-riboflavin cross-linking of the cornea.

Authors:  Eberhard Spoerl; Michael Mrochen; David Sliney; Stephen Trokel; Theo Seiler
Journal:  Cornea       Date:  2007-05       Impact factor: 2.651

4.  [Regeneration of corneal endothelium in the rabbit: microscopic study and relation with corneal thickness].

Authors:  M Hirsch; J P Faure; O Marquet; P Payrau
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1975-03

5.  Fungal endophthalmitis successfully treated with intravitreal voriconazole injection.

Authors:  Yohei Funakoshi; Kimikazu Yakushijin; Hiroshi Matsuoka; Hironobu Minami
Journal:  Intern Med       Date:  2011-04-15       Impact factor: 1.271

Review 6.  Diagnostic and therapeutic considerations in fungal keratitis.

Authors:  Han-Ying Peggy Chang; James Chodosh
Journal:  Int Ophthalmol Clin       Date:  2011

7.  Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.

Authors:  Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

8.  Update on fungal keratitis from 1999 to 2008.

Authors:  Elvin H Yildiz; Yasmine F Abdalla; Ahmed F Elsahn; Christopher J Rapuano; Kristin M Hammersmith; Peter R Laibson; Elisabeth J Cohen
Journal:  Cornea       Date:  2010-12       Impact factor: 2.651

9.  [Reproducible model of a bacterial conjunctivitis].

Authors:  W Behrens-Baumann; T Begall
Journal:  Ophthalmologica       Date:  1993       Impact factor: 3.250

10.  Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates.

Authors:  Linu Pradhan; Savitri Sharma; Suma Nalamada; Srikant K Sahu; Sujata Das; Prashant Garg
Journal:  Indian J Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 1.848

View more
  5 in total

1.  Corneal collagen cross-linking for bacterial infectious keratitis.

Authors:  Shadi A Davis; Renee Bovelle; Genie Han; John Kwagyan
Journal:  Cochrane Database Syst Rev       Date:  2020-06-17

2.  Integrated transcriptomic analysis of Trichosporon Asahii uncovers the core genes and pathways of fluconazole resistance.

Authors:  Haitao Li; Congmin Wang; Yong Chen; Shaoqiang Zhang; Rongya Yang
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

3.  Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis.

Authors:  Ziqian Zhu; Hongmin Zhang; Juan Yue; Susu Liu; Zhijie Li; Liya Wang
Journal:  BMC Ophthalmol       Date:  2018-03-02       Impact factor: 2.209

4.  Fungal keratitis: study of increasing trend and common determinants.

Authors:  Yogesh Acharya; Bhawana Acharya; Priyanka Karki
Journal:  Nepal J Epidemiol       Date:  2017-06-30

5.  Rabbit Fungal Keratitis Model of Fusarium solani Tested Against Three Commercially Available Antifungal Drugs.

Authors:  Thet Tun Aung; Wei Hong Jeff Chor; Myoe Naing Lynn; Anita Sook Yee Chan; Donald T H Tan; Roger W Beuerman
Journal:  Eye Contact Lens       Date:  2020-09       Impact factor: 3.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.